China Universal Asset Management Co., Ltd. Ascendis Pharma A/S Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 12,789 shares of ASND stock, worth $1.64 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
12,789
Previous 11,142
14.78%
Holding current value
$1.64 Million
Previous $1.66 Million
5.83%
% of portfolio
0.17%
Previous 0.19%
Shares
15 transactions
Others Institutions Holding ASND
# of Institutions
241Shares Held
58.8MCall Options Held
250KPut Options Held
377K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.24 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.13MShares$658 Million3.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$640 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.41MShares$566 Million1.03% of portfolio
-
Janus Henderson Group PLC London, X04.19MShares$537 Million0.33% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.15B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...